Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galantamine and Nimodipine in Mixed Dementia
NCT00814658Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in mixed dementia comparing Galantamine + Nimodipine with Galantamine + Placebo (2 arms). Primary endpoints: Reaction Time for Simple Reaction Time Test at Week 24, Reaction Time for Two-choice Reaction Time Test at Week 24 and 4 more. Started Jun 2008; status: completed.
02
Drugs
nimodipine
03
Conditions
mixed dementia
Beyond the preview
Go deeper on NCT00814658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00814658.